MD Pharma Consulting Group

MD Pharma Consulting Group is a Canadian CRO offering innovative consultations and executive solutions to various stakeholders in the biopharmaceutical and medical device industry. The company focuses on pharmacovigilance, medical affairs, benefit-risk assessment, risk management, medical monitoring, data management, product management, statistics and data analysis, health economic outcomes research, market research, and medical writing. Operating from its headquarters in the GTA, ON, Canada, MD Pharma Consulting Group has recently expanded its operations to the MENA region, establishing a new regional office in Cairo, Egypt. The company's dedication to science, evidence-based practices, and quality services positions it as a top-notch service provider in the industry. While specific information about the founding date, industries, and last investment remains undisclosed, MD Pharma Consulting Group's expansion into the MENA region indicates a strategic move to tap into emerging markets and diversify its client base. However, the lack of publicly available data on the recent investment and investors makes it challenging to gauge the company's financial backing and potential partnerships. As MD Pharma Consulting Group continues to fortify its presence in both established and emerging markets, industry observers may anticipate further developments in its operational scale and potential collaborations within the biopharmaceutical and medical device sectors.